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ABStrACt
We welcome Ballantyne & Schaefer’s 
discussion of the issues concerning consent 
and use of health data for research. In 
response to their acknowledgement of 
the need for public debate and discussion, 
we provide evidence from our own public 
consultation on this topic.
Ballantyne and Schaefer outline some of 
the debates around the use of personal 
health information for the purposes of 
research.1 Specifically, they discuss 
whether ‘citizens have an ethical obliga-
tion to share their health information for 
research purposes’, and propose a model 
for rethinking traditional research ethics 
frameworks with a shift to focussing on 
the public good of the research, public 
engagement and transparency. We wish to 
contribute a crucial missing part of the 
argument: patient and public attitudes 
toward the use of health information for 
research.
In recent years, there have been huge 
technological advances for using the 
wealth of information contained within 
health records, and specifically electronic 
health records (EHRs), for research. As 
Ballantyne and Schaefer highlight, the 
secondary use of health data has a number 
of advantages over traditional research in 
producing meaningful health knowledge 
that is of public benefit. While the poten-
tial for the use of health data for research 
is clear, addressing the legal and ethical 
challenges in accessing and analysing large 
amounts of patient data is complex. The 
advancement of technologies allowing for 
the de-identification or pseudonymisation 
of EHRs have helped to address some of 
these issues and led to waivers of consent 
in some jurisdictions but not all.
Debates around consent and confiden-
tiality have often made assumptions about 
what patients may find acceptable, but 
there has been limited engagement with 
patients and the public to explore these 
complex issues.2 3 We agree with Ballan-
tyne and Schaefer that progress in this 
area requires engagement with patients 
and the public to ensure ongoing trust and 
to develop the best models of security. We 
undertook a small public consultation to 
inform and support the ethical approval 
and governance process for the use of a 
new information retrieval platform4 to use 
local EHRs for research. The consultation 
was advertised through existing patient 
and public involvement groups, volunteer 
lists and the hospital’s member bulletin. 
Interested patients and family members 
were invited to attend one of two focus 
groups each lasting 2 hours. A total of 13 
individuals attended the two focus groups 
with representation across 10 different 
clinical specialties and a range of services 
within the local hospital. Patients were 
invited to discuss: their views towards 
the use of de-identified data; the poten-
tial benefits of using hospital records for 
research; what might concern and what 
might reassure them; what information 
would be important for them to know if 
their data were to be used for research; 
what consent means to them; and how 
they feel about being approached to 
participate in research.
Overall, there was support for the use 
of EHRs for the purposes of research and 
a clear recognition of the benefits and 
opportunities provided they were used 
in a de-identified format. All participants 
agreed on the importance of research for 
the development of new treatments and 
for improving direct patient care. Many 
patients spoke about a desire to ‘give 
something back’ for the care received and 
saw the use of their de-identified health 
records for research as a way to do this. 
Patients discussed some important areas 
of concern which echo the consider-
ations raised and discussed by Ballantyne 
and Schaefer. In particular, the patients 
in our consultation expressed concerns 
about data handling, security and access 
(especially by external agencies such as 
pharmaceutical companies). Regardless 
of anonymisation or de-identification, 
patients were unanimously against the use 
of their data for commercial gains. This 
reflects previous studies demonstrating 
that the recipient of data is the most 
important factor in determining willing-
ness for allowing data to be shared.5 6 The 
discussion highlighted the importance of 
having adequate information governance 
arrangements and effective information 
technology safeguards, while recognising 
that such policies will be complex. Patients 
were enthusiastic about a patient-led 
committee or advisory group which 
would review requests to obtain access 
to data in order to ensure patient safety 
as well as assess the value of proposed 
research, which is in keeping with Ballan-
tyne and Schaefer’s suggestion on prere-
search consultation as well as ongoing 
partnership and/or patient involvement in 
research governance.
Related to autonomy and public trust, 
patients expressed a common wish to 
be informed of the use of their data for 
research and clear instructions on how to 
opt-out if desired. Ballantyne and Schaefer 
state that the violation of autonomy 
is kept relatively minimal if restricting 
their proposed model to secondary data 
research. Based on patient and public 
views, we would add that the provi-
sion of opt-out processes where possible 
would minimise this even further. Patients 
also want know to how their data are 
being used. Attitudes toward the use of 
personal information for the purposes 
of research are influenced by the nature 
of the information itself, what it will be 
used for and who might see it.7 Echoing 
some of the ‘transparency mechanisms’ 
discussed, patients advocated for waiting 
room posters and short videos informing 
patients of both the use of de-identified 
data for research and the subsequent 
results of such research. Importantly, it was 
agreed that this information should come 
from and be promoted by a wide range 
of interested parties, not just researchers. 
Ongoing discussion, education, communi-
cation and collaboration with patients, as 
well as other stakeholders, are vital.
There is also the potential to use 
EHRs for the identification of potential 
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participants for future interventional 
research. While we agree with Ballan-
tyne and Schaefer that conscription into 
interventional research should not be 
advocated, the opportunities for volun-
tary participation of targeted groups can 
be enhanced. In this regard, a process 
called ‘consent for contact’ (C4C) has 
been developed whereby individuals can 
give generic consent, which is recorded 
on their EHR, to be contacted about 
suitable research opportunities, before 
considering whether they consent to take 
part in any given interventional research.8 
This provides a flexible and autonomous 
way of obtaining consent to be contacted, 
without any obligations for actual partic-
ipation. Patients were willing to consider 
a C4C arrangement allowing researchers 
access to their contact details in order to 
be approached for active engagement in 
studies. However, in this instance, they 
were explicit that this must be an opt-in 
process discussed with them by someone 
trusted and familiar (eg, a known clini-
cian). They were happy for this consent, 
once given, to be ongoing and valid across 
their spectrum of care provided they were 
given the appropriate time and informa-
tion to allow them to make an informed 
choice to opt-in or not, and that the option 
of opting-out is available and the process 
for this made clear. C4C (or similar) initia-
tives using such an opt-in process have 
been successfully implemented in different 
secondary and tertiary care settings.9 10
We strongly agree that service user and 
stakeholder consultation is key for the 
future development and management of 
any model using health data for research. 
It is reassuring that the perspectives and 
considerations raised by Ballantyne and 
Schaefer and the wider research commu-
nity are on the whole reflective of those 
raised by patients and the public in our 
consultation. Framing the use of health 
data in research as an obligation neglects 
the reality that some patients view the use 
of their data as positive and have a desire 
to give back. We hope that further public 
engagement is prompted by these debates.
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